Callis (L. ‘kœl∙is): forest path There are a lot of trees in the forest of your project – the underlying science, preclinical and clinical data, unique therapeutic considerations, patient epidemiology, competition, sales forecasts, developing market and regulatory trends. CallisBio has a track record of success mastering those details, identifying key elements to effectively persuade your stakeholders, and setting your path to a successful transaction whether it’s a license, collaboration, acquisition, or financing. We can help you with your corporate and business development needs from strategy through campaign implementation and deal closing including valuation, diligence, and negotiation.